About VivaBioCell
VivaBioCell is a Healthcare company based in Udine (Italy) founded in 2007, and was acquired by NantWorks in June 2015. Medical treatments are developed via cell therapeutics and tissue engineering. VivaBioCell offers products and services including NANT XL System, NANT 001 System, and NANT Maestro. Its focus areas include Diversified Pharmaceuticals, Life Sciences, Cell Therapy and Stem Cells. Its legal entity is VivaBioCell S.p.A.
Company details
VivaBioCell develops medical treatments based on cell therapeutics and tissue engineering. The company has developed an automated GMP-in-a-box, a continuous cell culture device. The devices uses autologous patient-specific granulocyte-macrophage progenitors. VivaBioCell plans to use the device for applications in stem cell treatments for osteoarthritis and bone regeneration for dental maxillofacial reconstruction. In addition, the company also has a diagnostic product for early diagnosis of autoimmune diseases such as systemic sclerosis and systemic lupus erythematosus. In June 2015, VivaBioCell was acquired by NantCell, a subsidiary of NantHealth.
- Headquarters Udine, Italy
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website vivabiocell.it/news
- Social LinkedIn
- Acquired by NantWorks (Jun 2015)
- Legal Name Vivabiocell S.P.A.
Products & Services of VivaBioCell
VivaBioCell offers a comprehensive portfolio of products and services, including NANT XL System, NANT 001 System, and NANT Maestro.
Automated platform for mid to large-scale cell batch expansion.
Automated solution for small to mid-scale cell manufacturing.
Interface for managing and monitoring cell factory systems.
Investors in VivaBioCell
VivaBioCell has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include NantWorks.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Network of technology and infrastructure companies focused on healthcare development | 2006 | nantworks.com | Culver City, United States |
Investor details for VivaBioCell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of VivaBioCell
2 dated milestones of VivaBioCell across 8 years, from founding to its latest funding, stage changes and deals.
- Founded VivaBioCell is founded.
- Exit Acquired by NantWorks.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VivaBioCell
VivaBioCell was founded in 2007.
VivaBioCell is headquartered in Udine, Italy. It is registered at Udine, Friuli-venezia Giulia, Italy.
VivaBioCell develops medical treatments based on cell therapeutics and tissue engineering. The company has developed an automated GMP-in-a-box, a continuous cell culture device. The devices uses autologous patient-specific granulocyte-macrophage progenitors. VivaBioCell plans to use the device for applications in stem cell treatments for osteoarthritis and bone regeneration for dental maxillofacial reconstruction. In addition, the company also has a diagnostic product for early diagnosis of autoimmune diseases such as systemic sclerosis and systemic lupus erythematosus. In June 2015, VivaBioCell was acquired by NantCell, a subsidiary of NantHealth.
VivaBioCell offers NANT XL System, NANT 001 System, and NANT Maestro.
VivaBioCell has 1 investor. Key investors include NantWorks.
VivaBioCell operates through Vivabiocell S.P.A..
Yes. VivaBioCell was acquired by NantWorks in June 2015.